ホーム>>Signaling Pathways>> Others>>Ro 08-2750

Ro 08-2750

カタログ番号GC17622

Ro 08-2750 は、非ペプチドで可逆的な神経成長因子 (NGF) 阻害剤であり、NGF に結合し、IC50 は ~ 1 μM です。

Products are for research use only. Not for human use. We do not sell to patients.

Ro 08-2750 化学構造

Cas No.: 37854-59-4

サイズ 価格 在庫数 個数
1mg
$45.00
在庫あり
5mg
$143.00
在庫あり
10mg
$265.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product has been cited by 1 publications

Description Chemical Properties Product Documents Related Products

Ro 08-2750 is a p75 neurotrophin receptor (p75NTR) ligand that completely inhibits nerve growth factor (NGF) binding to p75NTR in PC12 cells when used at a concentration of 100 μM.[1] It also binds to NGF dimers (Kd = ~1 μM) to induce a conformational change that prevents NGF binding to p75NTR or tropomyosin-related kinase A (TrkA). Ro 08-2750 inhibits NGF-induced death of SK-N-MC cells and inhibits autophosphorylation of TrkA in PC12 cells. It reverses NGF-induced decreases in β-catenin mRNA expression in, and migration of, SKOV3 and OVCAR-3 ovarian cancer cells.[2]

Reference:
[1]. Niederhauser, O., Mangold, M., Schubenel, R., et al. NGF ligand alters NGF signaling via p75NTR and trkA. J. Neurosci. Res. 61(3), 263-272 (2000).
[2]. Li, B., Cai, S., Zhao, Y., et al. Nerve growth factor modulates the tumor cells migration in ovarian cancer through the WNT/β-catenin pathway. Oncotarget 7(49), 81026-81048 (2016).

レビュー

Review for Ro 08-2750

Average Rating: 5 ★★★★★ (Based on Reviews and 27 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Ro 08-2750

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.